Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

FranceBack to France

Clinical trials in Belfort

2 clinical trials in Belfort, France across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

FranceOur site in FranceEssaisCliniques.fr(opens in a new tab)
Belfort at a glance
2
clinical trials
  • Paediatric trials0
  • Research sites1
Type of trial
Recruitment status
Quick filters

2 trials in Belfort

Open in trial search

Bronchopulmonary aspergillosis

Recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Itraconazole
  • Sponsor:Centre Hospitalier Universitaire De Poitiers

Sepsis

Not yet recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Dexmedetomidine
  • Sponsor:Hospices Civils De Lyon

Other cities in France

The busiest research cities in the country

All 379 cities in France

Clinical research in Belfort

What the registry says about research in the country

01 Belfort
Respiratory and Circulatory Physiology
The clinical research activity in Belfort focuses on a small but clearly targeted set of studies within Phenomena and Processes, especially Circulatory and Respiratory Physiological Phenomena. These trials are examining how treatments may improve patient outcomes in serious lung and blood-circulation-related conditions. Research in Chronic pulmonary aspergillosis is assessing better control of persistent fungal lung disease Studies in Septic shock are exploring ways to support critically ill patients with severe circulatory failure Clinical work is aimed at comparing treatment effectiveness and improving patient survival and recovery This area brings together respiratory and intensive care research, with a focus on evaluating whether new or combined approaches can provide stronger clinical benefit than standard care alone.
Pulmonary Infection and Antifungal Care
One line of research is centered on Chronic pulmonary aspergillosis, a long-term fungal infection affecting the lungs. The studies are designed to test whether adding another therapy can improve both clinical response and imaging results in patients with limited immune suppression. Focus on persistent fungal lung infection and treatment response Evaluation of whether combination therapy offers added benefit over standard antifungal care Interest in both symptom improvement and radiological outcomes These trials help clarify how best to manage a difficult respiratory condition where long-term control is often a challenge.
Critical Care and Septic Shock Research
Another study area examines Septic shock in mechanically ventilated patients, with attention on treatments that may improve outcomes in severe, refractory cases. The goal is to see whether an added supportive therapy can reduce mortality alongside standard critical care. Research on severe infection-related shock and organ support Assessment of adjunctive treatment for patients not responding well to usual care Outcome focus on short-term survival in intensive care settings This work supports efforts to strengthen treatment strategies for one of the most urgent emergencies in intensive care medicine.
Back to FranceAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.